ECMO Treatment of Children in China in the Past 10 Years

NCT04709432 · tracked via the Priya Life Science China tracker

Sponsor

Children's Hospital of Fudan University

Phase

Observational

Started

2021-01-11

Last updated

2026-03-16

Condition(s) studied

Extracorporeal Membrane OxygenationChild, Only

Investigational drug(s) / intervention(s)

ECMO

ECMO: ECMO is a form of Extracorporeal Life Support (ECLS) to support either the pulmonary, or both the pulmonary and cardiac systems.

Study summary

It is a cross-sectional study to summarize the extracorporeal membrane oxygenation （ECMO）treatment in children in China.

Eligibility

Sex

ALL

Min age

1 Day

Max age

18 Years

Healthy volunteers

Inclusion Criteria: * age of 1d to 18 years old; * children supported by ECMO in mainland China in the past 10 years Exclusion Criteria: * none

Primary outcome measure(s)

survival rate — from admission to discharge （about 10days）
survival rate after discharge

Trial sites (1)

Facility	City	Region	Status
Children's Hospital of Fudan University	Shanghai	Shanghai Municipality	Recruiting

More Children's Hospital of Fudan University trials in China

Clinical Cohort Study of DHA in Neurodevelopmental Disorders Active, not recruiting

A Long-term Follow-up Study in Participants Who Received CS-101 Recruiting

Effects of Intermittent Dietary Restriction on Cardiometabolic Risk in School-aged Children Recruiting

Preoperative Serum FGF19 in the Prognosis of Biliary Atresia Recruiting

Differences in Prosocial Behaviors and Related Brain Networks in Children With Autism and Typical Development Recruiting

Other trials for the same condition

Mechanism of Nitric Oxide on Ventilator-induced Diaphragm Dysfunction with Extracorporeal Membrane Lung Assistance Active, not recruiting

Effect of Transpulmonary MP on Prognosis of Patients With Severe ARDS Treated With VV-ECMO Recruiting

Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients Recruiting

Evaluation of Membrane Lung Function in High-altitude Regions Recruiting

Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCT Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04709432 on ClinicalTrials.gov ↗ ← All trials in China